Expression of survivin in oral potentially malignant disorders: An immunohistochemical study

被引:0
|
作者
Rajanna, Venkatraman R. [1 ]
Raveendranath, Murali C. [1 ]
Kathiresan, Shanmugam [1 ]
Srinivasan, Soundarya [1 ]
Ilango, Janani [1 ]
机构
[1] Best Dent Sci Coll & Hosp, Dept Oral Pathol & Microbiol, Madurai 625104, Tamil Nadu, India
来源
JOURNAL OF PHARMACY AND BIOALLIED SCIENCES | 2020年 / 12卷
关键词
Immunohistochemistry; oral leukoplakia; oral lichen planus; oral submucous fibrosis; prognostic marker; survivin; SQUAMOUS-CELL CARCINOMA; MOLECULAR BIOMARKER; SUBMUCOUS FIBROSIS; LICHEN-PLANUS; CARCINOGENESIS; APOPTOSIS; NUCLEAR; CANCER;
D O I
10.4103/jpbs.JPBS_114_20
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aim: The aim of this study was to compare the immunohistochemical expression of survivin in oral potentially malignant disorders (OPMDs) and evaluate its prognostic significance among oral leukoplakia (OL), oral submucous fibrosis (OSMF), and oral lichen planus (OLP). Materials and Methods: The study material consisted of 60 formalin-fixed paraffin-embedded tissue samples: 15 cases each of OL, OSMF, OLP, and normal oral mucosal epithelium as control. Survivin expression was analyzed immunohistochemically, and data analysis was accomplished using Statistical Package for Social Sciences, version 22.0 (SPSS Inc., Chicago, IL). Fisher's chi-square test was opted to compare the study groups. Results: Survivin was expressed in all the OPMDs including OL, OSMF, and OLP, but was absent in normal oral tissue samples. Higher immunoreactivity and survivin staining was observed in OLP compared to OL and OSMF whereas OL showed a significant difference in the distribution of survivin immunoexpression against OLP. An increased nuclear expression of survivin along with distribution in the basal and parabasal layers was evident in all OPMDs. Conclusion: Survivin was expressed more in OLP in comparison to OSMF and OLP, indicating unfavorable prognosis. OL showed increased expression in comparison to OSMF, showing unfavorable prognosis. On the basis of this study, it was concluded that survivin may be used as an important diagnostic and prognostic marker for OPMDs.
引用
收藏
页码:382 / 388
页数:7
相关论文
共 50 条
  • [1] Immunohistochemical Characterization of Bcl-2 in Oral Potentially Malignant Disorders
    Chamorro-Petronacci, Cintia M.
    Lafuente-Ibanez De Mendoza, Irene
    Suarez-Penaranda, Jose M.
    Padin-Iruegas, Elena
    Blanco-Carrion, Andres
    Lorenzo-Pouso, Alejandro, I
    Ortega, Karem L.
    Perez-Sayans, Mario
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2021, 29 (09) : 706 - 712
  • [2] Consensus guidelines on management of oral potentially malignant disorders
    Birur, Praveen N.
    Patrick, Sanjana
    Warnakulasuriya, Saman
    Gurushanth, Keerthi
    Raghavan, Shubhasini A.
    Rath, Goura K.
    Chaturvedi, Pankaj
    Chandru, Vijay
    Mathew, Babu
    Prabhash, Kumar
    Gurudath, Shubha
    Mukhia, Nirza
    Sunny, Sumsum P.
    Mehrotra, Ravi
    Vivek, V.
    Patil, Shankargouda
    Kumar, Suresh G.
    Fasalkar, Shruthi
    Pratima, Rao
    Kuriakose, Moni A.
    INDIAN JOURNAL OF CANCER, 2022, 59 (03) : 442 - 453
  • [3] Impact of oral potentially malignant disorders on quality of life
    Tadakamadla, Jyothi
    Kumar, Santhosh
    Lalloo, Ratilal
    Babu, Dara Balaji Gandhi
    Johnson, Newell W.
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2018, 47 (01) : 60 - 65
  • [4] Malignant transformation of oral potentially malignant disorders in males: a retrospective cohort study
    Ho, Pei-Shan
    Chen, Pai-Li
    Warnakulasuriya, Saman
    Shieh, Tien-Yu
    Chen, Yun-Kwan
    Huang, I-Yueh
    BMC CANCER, 2009, 9
  • [5] Oral Potentially Malignant Disorders: Etiology, Pathogenesis, and Transformation Into Oral Cancer
    Kumari, Pratima
    Debta, Priyanka
    Dixit, Anshuman
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [6] Immunohistochemical Expression of Differentiated Embryonic Chondrocyte 1 and Cluster of Differentiation 44 in Oral Potentially Malignant Disorders
    Onofrei, Bianca-Andreea
    Apostol, Delia Gabriela Ciobanu
    Tanasa, Madalina-Gabriela
    Baciu, Elena-Raluca
    Popa, Cristina
    Sciuca, Ana Maria
    Toader, Mihaela Paula
    Costan, Victor-Vlad
    MEDICINA-LITHUANIA, 2025, 61 (02):
  • [7] Evaluation and Expression of Survivin in Potentially Malignant Lesions and Squamous Cell Carcinoma: A Comparative Study
    Sakthivel, Rekhaa
    Ramamoorthy, Ananthalakshmi
    Jeddy, Nadeem
    Singaram, Mamta
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (04)
  • [8] Management of oral potentially malignant disorders
    Kerr, Alexander Ross
    Lodi, Giovanni
    ORAL DISEASES, 2021, 27 (08) : 2008 - 2025
  • [9] A new classification for potentially malignant disorders of the oral cavity
    Sarode, Sachin C.
    Sarode, Gargi S.
    Karmarkar, Swarada
    Tupkari, Jagdish V.
    ORAL ONCOLOGY, 2011, 47 (09) : 920 - 921
  • [10] Immunohistochemical Expression of Epidermal Growth Factor Receptor (EGFR) in Oral Squamous Cell Carcinoma and Oral Potentially Malignant Disorders
    Aamir, Razia
    Rauf, Fozia
    Iqbal, Fatima
    Yousuf, Sarah
    Rehman, Asif
    Sheikh, Ahmareen K.
    Muhammad, Sardar
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2024, 32 (03) : 157 - 162